CN1297317C - 组合物在制备治疗病毒性感染的药物中的用途 - Google Patents
组合物在制备治疗病毒性感染的药物中的用途 Download PDFInfo
- Publication number
- CN1297317C CN1297317C CNB008143579A CN00814357A CN1297317C CN 1297317 C CN1297317 C CN 1297317C CN B008143579 A CNB008143579 A CN B008143579A CN 00814357 A CN00814357 A CN 00814357A CN 1297317 C CN1297317 C CN 1297317C
- Authority
- CN
- China
- Prior art keywords
- quercetin
- chloroquine
- quinoline
- purposes
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15026199P | 1999-08-23 | 1999-08-23 | |
US60/150,261 | 1999-08-23 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006101604837A Division CN1994466A (zh) | 1999-08-23 | 2000-08-23 | 组合物在制备治疗病毒性感染的药物中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1399558A CN1399558A (zh) | 2003-02-26 |
CN1297317C true CN1297317C (zh) | 2007-01-31 |
Family
ID=22533745
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008143579A Expired - Fee Related CN1297317C (zh) | 1999-08-23 | 2000-08-23 | 组合物在制备治疗病毒性感染的药物中的用途 |
CNA2006101604837A Pending CN1994466A (zh) | 1999-08-23 | 2000-08-23 | 组合物在制备治疗病毒性感染的药物中的用途 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006101604837A Pending CN1994466A (zh) | 1999-08-23 | 2000-08-23 | 组合物在制备治疗病毒性感染的药物中的用途 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1210116B1 (zh) |
CN (2) | CN1297317C (zh) |
AP (1) | AP1691A (zh) |
AT (1) | ATE350061T1 (zh) |
AU (1) | AU775903B2 (zh) |
DE (1) | DE60032777T2 (zh) |
WO (1) | WO2001013907A2 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7479498B2 (en) * | 1999-08-23 | 2009-01-20 | Phoenix Biosciences, Inc. | Treatments for viral infections |
CN1319531C (zh) * | 2005-06-08 | 2007-06-06 | 复旦大学 | 喹啉类生物碱在制备抗乙肝病毒药物中的用途 |
US8889743B2 (en) * | 2007-06-20 | 2014-11-18 | Board Of Regents, University Of Texas System | Inhibition of filovirus entry into cells and uses thereof |
SG11201405018VA (en) * | 2012-03-30 | 2014-09-26 | Univ Malaya | A composition having antiviral activity against flavivirus |
ES2844927T3 (es) * | 2016-06-28 | 2021-07-23 | Hopitaux Paris Assist Publique | Derivados de primaquina para la utilización en la prevención y/o el tratamiento de trastornos asociados al virus herpes gamma |
CN109820852B (zh) * | 2019-03-11 | 2021-02-19 | 中国农业科学院兰州兽医研究所 | 一种尼莫地平在制备预防口蹄疫病毒感染的药物中的应用 |
FR3109723A1 (fr) * | 2020-05-04 | 2021-11-05 | Dyna + | Composition de renforcement et/ou de régulation de la réponse immunitaire |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4897403A (en) * | 1986-11-18 | 1990-01-30 | The United States Of America As Represented By The Secretary Of The Army | Antimalarial compositions and methods |
US5278173A (en) * | 1988-06-30 | 1994-01-11 | Davis Michael H | Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo |
US5430039A (en) * | 1990-09-28 | 1995-07-04 | Cephalon, Inc. | Treatment of neurological disorders |
-
2000
- 2000-08-23 DE DE60032777T patent/DE60032777T2/de not_active Expired - Fee Related
- 2000-08-23 AT AT00955850T patent/ATE350061T1/de not_active IP Right Cessation
- 2000-08-23 AU AU67988/00A patent/AU775903B2/en not_active Ceased
- 2000-08-23 CN CNB008143579A patent/CN1297317C/zh not_active Expired - Fee Related
- 2000-08-23 CN CNA2006101604837A patent/CN1994466A/zh active Pending
- 2000-08-23 EP EP00955850A patent/EP1210116B1/en not_active Expired - Lifetime
- 2000-08-23 WO PCT/US2000/023123 patent/WO2001013907A2/en active IP Right Grant
- 2000-08-23 AP APAP/P/2002/002432A patent/AP1691A/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4897403A (en) * | 1986-11-18 | 1990-01-30 | The United States Of America As Represented By The Secretary Of The Army | Antimalarial compositions and methods |
US5278173A (en) * | 1988-06-30 | 1994-01-11 | Davis Michael H | Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo |
US5430039A (en) * | 1990-09-28 | 1995-07-04 | Cephalon, Inc. | Treatment of neurological disorders |
Also Published As
Publication number | Publication date |
---|---|
CN1994466A (zh) | 2007-07-11 |
AP2002002432A0 (en) | 2002-03-31 |
WO2001013907A3 (en) | 2001-08-30 |
AP1691A (en) | 2006-12-11 |
WO2001013907A2 (en) | 2001-03-01 |
ATE350061T1 (de) | 2007-01-15 |
AU775903B2 (en) | 2004-08-19 |
AU6798800A (en) | 2001-03-19 |
CN1399558A (zh) | 2003-02-26 |
DE60032777D1 (de) | 2007-02-15 |
EP1210116B1 (en) | 2007-01-03 |
EP1210116A2 (en) | 2002-06-05 |
DE60032777T2 (de) | 2007-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60121096T2 (de) | Methode zur Behandlung von Fettsucht anhand eines Neurotensinreceptor-Liganden | |
AU2019203448A1 (en) | Fenfluramine for use in the treatment of dravet syndrome | |
CN1301158A (zh) | 用于治疗人类获得性免疫缺陷病毒和其它病毒感染的组合物 | |
Shreekant et al. | 4-Aminoquinolines: an overview of antimalarial chemotherapy | |
KR20080081358A (ko) | Hiv 인테그라제 억제제의 약동학을 개선하기 위한 방법 | |
WO2003050129A1 (en) | Use of phosphonate nucleotide analogue for treating hepatitis b virus infections | |
CN1297317C (zh) | 组合物在制备治疗病毒性感染的药物中的用途 | |
US6734192B1 (en) | Treatment of viral infections | |
AU614515B2 (en) | A pharmaceutical combination for the prophylaxis and therapy of malaria | |
JP3208138B2 (ja) | ウイルス性肝炎の診断及び治療 | |
Hache et al. | Combination of hydroxychloroquine plus azithromycin as potential treatment for COVID 19 patients: pharmacology, safety profile, drug interactions and management of toxicity | |
JP5469095B2 (ja) | 急性マラリアを治療するためのビス−チアゾリウム塩またはこれらの前駆体およびアルテミシニンまたはこれらの誘導体の組み合わせ | |
WO2014205179A1 (en) | Ribonucleotide reductase inhibitors sensitize tumor cells to dna damaging agents | |
JPWO2006046528A1 (ja) | 糸球体疾患治療剤 | |
JP2000191531A (ja) | 抗マラリア剤 | |
EP0555302A1 (en) | Method of treating demyelinating disease | |
JP2011037814A (ja) | マラリア原虫疾患予防又は治療用の5−ヘテロ環置換イミノ−9−ジアルキルアミノベンゾ[a]フェノキサチン化合物又はその塩とアーテミシニン誘導体との組み合わせ | |
JPH0873355A (ja) | 抗マラリア薬耐性克服剤 | |
US20220265644A1 (en) | Fixed dose combination drug for the treatment of malaria | |
Koren et al. | SCIENTIFIC BASIS OF ANTIRETROVIRAL THERAPY | |
EP1200093A2 (en) | Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders | |
US20080233128A1 (en) | Treatment of Viral Infections | |
Uwah et al. | Artesunate-Amodiaquine and Ciprofloxacin Combination Improves Biochemical and Histological Markers of Renal Function of Malaria Infected Mice | |
IL298748A (en) | Use of a combination of colchicine and a CXCR-2 inhibitor for the treatment or prevention of hereditary Mediterranean fever (FMF) and its outbreaks | |
Safeukui et al. | Simultaneous adjunctive treatment of malaria and its co-evolved genetic disorder sickle cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MP-1 CO.,LTD. Free format text: FORMER OWNER: IMMUNE BALANCE TECHNOLOGIES CO., LTD. Effective date: 20041217 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20041217 Address after: American Florida Applicant after: MP-1 company Address before: American Florida Applicant before: Immune Balance Technologies Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: PHOENIX BIOLOGY SCIENCE CO., LTD. Free format text: FORMER OWNER: MP-1 CO.,LTD. Effective date: 20051028 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20051028 Address after: American Florida Applicant after: Phoenix bioscience Inc Address before: American Florida Applicant before: MP-1 company |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070131 Termination date: 20110823 |